| Andrew P. Hider | President and CEO | FY2025 | |
| Joel Grade | Former Executive Vice President and CFO | FY2025 | |
| José E. Almeida | Former Chair of the Board, President and CEO | FY2025 | |
| Heather Knight | Former Executive Vice President, COO and Interim Group President, Medical Products & Therapies | FY2025 | |
| Reazur Rasul | Executive Vice President and Group President, Healthcare Systems & Technologies | FY2025 | |
| Alok Sonig | Former Executive Vice President and Group President, Pharmaceuticals | FY2025 | |
| D. Brent Shafer | Non-Executive Chair and Former Executive Chair and Interim CEO | FY2025 | |
| David Rosenbloom | Executive Vice President and General Counsel | FY2025 | |
| Cecilia Soriano | Group President, Infusion Therapies & Technologies and Pharmaceuticals | FY2025 |
9 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.